Literature DB >> 19136436

Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Maxim C-J Cheeran1, James R Lokensgard, Mark R Schleiss.   

Abstract

Congenital cytomegalovirus (CMV) infection is the leading infectious cause of mental retardation and hearing loss in the developed world. In recent years, there has been an improved understanding of the epidemiology, pathogenesis, and long-term disabilities associated with CMV infection. In this review, current concepts regarding the pathogenesis of neurological injury caused by CMV infections acquired by the developing fetus are summarized. The pathogenesis of CMV-induced disabilities is considered in the context of the epidemiology of CMV infection in pregnant women and newborn infants, and the clinical manifestations of brain injury are reviewed. The prospects for intervention, including antiviral therapies and vaccines, are summarized. Priorities for future research are suggested to improve the understanding of this common and disabling illness of infancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136436      PMCID: PMC2620634          DOI: 10.1128/CMR.00023-08

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  288 in total

1.  Characterization of host immunity to cytomegalovirus pp150 (UL32).

Authors:  Corinna La Rosa; Zhongde Wang; Simon F Lacey; Susan F Markel; Madeva C Sharma; Joybelle Martinez; Maria M Lalimarmo; Don J Diamond
Journal:  Hum Immunol       Date:  2005-02       Impact factor: 2.850

Review 2.  Insights into viral transmission at the uterine-placental interface.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Takako Tabata
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 3.  The specification of early hematopoiesis in the mammal.

Authors:  Margaret H Baron; Stuart T Fraser
Journal:  Curr Opin Hematol       Date:  2005-05       Impact factor: 3.284

Review 4.  Cell death suppression by cytomegaloviruses.

Authors:  V S Goldmacher
Journal:  Apoptosis       Date:  2005-03       Impact factor: 4.677

5.  Cytomegalovirus in the perilymphatic fluid.

Authors:  Paul W Bauer; Mojgan Parizi-Robinson; Peter S Roland; Subramanian Yegappan
Journal:  Laryngoscope       Date:  2005-02       Impact factor: 3.325

Review 6.  Congenital cytomegalovirus infection: outcome and diagnosis.

Authors:  Shannon A Ross; Suresh B Boppana
Journal:  Semin Pediatr Infect Dis       Date:  2005-01

7.  Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia.

Authors:  M Deshpande; J Zheng; K Borgmann; R Persidsky; L Wu; C Schellpeper; A Ghorpade
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

Authors:  Daniel N Streblow; Craig N Kreklywich; Patricia Smith; Jordana L Soule; Christine Meyer; Michael Yin; Patrick Beisser; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

9.  Growth of Listeria monocytogenes in the guinea pig placenta and role of cell-to-cell spread in fetal infection.

Authors:  Anna I Bakardjiev; Brian A Stacy; Daniel A Portnoy
Journal:  J Infect Dis       Date:  2005-04-26       Impact factor: 5.226

10.  Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures.

Authors:  Isao Kosugi; Hideya Kawasaki; Takashi Tsuchida; Yoshihiro Tsutsui
Journal:  Acta Neuropathol       Date:  2005-03-10       Impact factor: 17.088

View more
  167 in total

Review 1.  The emerging role of nuclear viral DNA sensors.

Authors:  Benjamin A Diner; Krystal K Lum; Ileana M Cristea
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

2.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

3.  Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study.

Authors:  Maik Dorn; Karen Lidzba; Andrea Bevot; Rangmar Goelz; Till-Karsten Hauser; Marko Wilke
Journal:  Hum Brain Mapp       Date:  2013-09-11       Impact factor: 5.038

4.  Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.

Authors:  Mark R Schleiss
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

5.  Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA.

Authors:  Jean-Philippe Belzile; Thomas J Stark; Gene W Yeo; Deborah H Spector
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

6.  CMV-induced embryonic mouse organ of corti dysplasia: Network architecture of dysfunctional lateral inhibition.

Authors:  Michael Melnick; Tina Jaskoll
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-07-14

Review 7.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

8.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

9.  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders.

Authors:  Ivan Gentile; Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Bubba; Laura Pellegrinelli; Domenico Scognamiglio; Francesca Operto; Lucia Margari; Guglielmo Borgia; Carmela Bravaccio
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

10.  An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.

Authors:  Mark R Schleiss; Ryan Buus; K Yeon Choi; Alistair McGregor
Journal:  Future Virol       Date:  2013-12-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.